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Anaemia is defined by the concentration of haemoglobin (Hb). However, this value
is dependent upon both the total circulating haemoglobin mass (tHb-mass) and the
plasma volume (PV) – neither of which is routinely measured. Carbon monoxide (CO)-
rebreathingmethods have been successfully used to determine both PV and tHb-mass
in various populations. However, these methods are not yet suitable for ventilated
patients. This study aimed to modify the CO-rebreathing procedure such that a single
inhalation of a CO bolus would enable its use in ventilated patients. Eleven healthy
volunteers performed four CO-rebreathing tests in a randomized order, inhaling an
identical CO volume. In two tests, CO was rebreathed for 2 min (optimized CO
rebreathing; oCOR), and in the other two tests, a single inhalation of a CO bolus was
conducted with a subsequent breath hold of 15 s (Procnew15s) or 30 s (Procnew30s).
Subsequently, the CO volume in the exhaled air was continuously determined for
20 min. The amount of CO exhaled after 7 and 20 min was respectively 3.1 ± 0.3
and 5.9 ± 1.1 ml for oCOR, 8.7 ± 3.6 and 12.0 ± 4.4 ml for Procnew15s and 5.1 ± 2.0
and 8.4 ±2.6 ml for Procnew30s. tHb-mass was 843 ± 293 g determined by oCOR,
821 ± 288 g determined by Procnew15s (difference: P < 0.05) and 849 ± 311 g
determined by Procnew30s. Bland–Altman plots demonstrated slightly lower tHb-mass
values for Procnew15s compared with oCOR (−21.8 ± 15.3 g) and similar values for
Procnew30s. In healthy volunteers, a single inhalationof aCObolus, preferably followed
by a 30 s breath hold, can be used to determine tHb-mass. These results must now be
validated for ventilated patients.
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1 INTRODUCTION
Haemoglobin (Hb) is the oxygen-carrying pigment of the circulation.
Its circulating concentration ([Hb]) is routinely measured in clinical
practice, and low values are used to define ‘anaemia’ (Beutler &
Waalen, 2006). However, [Hb] is determined by the total circulating
mass of Hb (tHb-mass) and the volume of plasma (PV) in which
it is carried. The measurement of such independent variables has
distinct advantages given that PV can change substantially with
disease. The importance of tHb-mass measurement in the clinical
setting and the advantages over [Hb] have been discussed previously
(Otto et al., 2017a,b; Plumb et al., 2016). Indeed, [Hb] correlates
poorly with tHb-mass in patients with chronic liver disease or heart
failure, in whom PV may be expanded (Otto et al., 2017a). Despite
this fact, [Hb] is the major trigger for the transfusion of red blood
cells.
Likewise, perioperative changes in tHb-mass and PV are
common (Iijima et al., 2013; Makaryus et al., 2018) due to blood
loss, administration of red blood cells or haemodilution through
administration of intravenous fluids or through salt/water retention
due to the ‘surgical stress response’ (Rassam & Counsell, 2005). Fluid
distribution between physiological compartments and the impact of
hypo/hypervolaemia on the glycocalyx and therefore the functional
integrity of the intravascular space also influence PV (Strunden et al.,
2011). However, the decision to transfuse blood to a patient in clinical
practice in general, and perioperative and critical care settings in
particular, hinges on a variety of factors. There is a growing recognition
that [Hb] may not be the best clinical indicator to guide such decisions
(Plumb et al., 2016; Shander & Ferraris, 2017).
tHb-mass and derived PV can be determined by different dilution
methods, in which carbon monoxide (CO) has been found to be
the easiest and most precise marker to use (Gore et al., 2005).
Using the inhalation of a known volume of CO (thus labelling Hb
as carboxyhaemoglobin, COHb) allows the measurement of tHb-
mass and, thus, the calculation of PV. In self-ventilating subjects, this
is achieved using the so-called ‘optimized CO rebreathing method’
(oCOR). However, this protocol relies upon the participant being alert,
able to follow instructions, and able to control their breathing through
a closed circuit, which in turn precludes the use of oCOR in participants
who are receiving mandatory ventilation from amechanical ventilator,
either under anaesthesia or when sedated in the intensive care unit.
We hypothesized that delivery of a single CO bolus into the breathing
circuit of a participant without the need for rebreathing could be used
to reliablymeasure tHb-mass, so long as exhaled gas could be analysed.
We thus sought to develop such a technique. Here, we describe this
development and early data relating to its likely reliability. The primary
aim of this study was to develop a new method for measuring tHb-
mass in healthy participants simulating a procedure that might be used
in participants on a mechanical ventilator (Procnew) and to evaluate
the feasibility of this novel method. We aimed to assess reliability
compared to the standard oCORmethod. We also repeated the oCOR
test to quantify the reliability of the standard method within this
experiment.
New Findings
∙ What is the central question of this study?
Is it possible to modify the CO-rebreathing method
to acquire reliable measurements of haemoglobin
mass in ventilated patients?
∙ What is themain finding and its importance?
A ‘single breath’ of CO with a subsequent 30 s
breath hold provides almost as exact a measure
of haemoglobin mass as the established optimized
CO-rebreathing method when applied to healthy
subjects. The modified method has now to be
checked in ventilated patients before it can be used
to quantify the contributions of blood loss and of
dilution to the severity of anaemia.
2 METHODS
2.1 Ethical approval
Ethical approval was granted by the South-Central Hampshire B
Research Ethics Committee (REC reference: 15/SC/0496) and from
the ethics committee of the University of Bayreuth (reference:
O1305/1-GB). The study conformed to the standards set by the
Declaration of Helsinki, except for registration in a database. Written
informed consent was obtained from all participants. The subjects
volunteered to participate in the study and were free to withdraw at
any timewithout needing to provide a reason.
2.2 Subjects
This feasibility study took place at the University Hospital
Southampton NHS Foundation Trust, UK, and at the University of
Bayreuth, Germany. Eleven healthy non-smoking test subjects (five
women, six men) with moderate physical training status took part in
the study (for anthropometric data of these subjects see Table 1).
2.3 Study design
In preliminary tests, we checked whether a single inhalation of a CO
bolus could achieve an increase in COHb concentration ([COHb]) that
would be sufficient to determine tHb-mass. For this purpose, tHb-mass
was measured twice; results from the established CO-rebreathing
method (Schmidt&Prommer, 2005), that is, 2minCO inhalationwithin
a closed spirometry system, were compared to those from a single
inhalation with subsequent 10 s breath holding and 15 min collection
of expired air. Because the difference in tHb-mass was lower than 50 g
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Age (years) 33.2 ± 11.6 26.8 ± 4.0
Height (cm) 165.5 ± 8.4 187.2 ± 9.8
Bodymass (kg) 59.2 ± 7.0 85.9 ± 10.9
BMI (kg/m2) 21.6 ± 1.1 24.4 ± 1.4
LBM (kg) 45.3 ± 6.9 72.2 ± 10.5
[Hb]cap (g/dl) 13.9 ± 0.7 15.9 ± 1.1
Hktcap (%) 41.8 ± 1.2 46.1 ± 3.0
[Hb]cap haemoglobin concentration determined in capillary blood, Hktcap,
haematocrit determined in capillary blood.
in only six of 13 comparisons, breath holding was prolonged to 15 and
30 s and collection of the expired air to 20min in themain study.
In the main study, at least four CO-rebreathing tests were carried
out by 11 subjects in a randomized order. Two of the tests consisted of
theestablishedCO-rebreathingmethodover2min (oCOR). In the third
and fourth tests, the subjects inhaled a CO bolus followed by a breath
hold for15 s (Procnew15s) or30 s (Procnew30s). Afterwards, the volume
andCOconcentration of the expiratory airwere continuously analysed
for 20 min, and the whole amount of exhaled air was finally collected
in a Douglas bag. tHb-mass was calculated at 2 min intervals using the
prevailing [COHb] and the accumulated CO volume in the expired air.
Additionally, at the end of the test, tHb-mass was obtained by using
the total expiratory volume and the average [COHb] in the Douglas
bag. To evaluate possible influences of the test arrangement, that is,
collection and analysis of the expired air after inhaling the CO bolus,
COexhalationwasdetermined fromsix subjects in a fifth test approach
using the same methodology as described above after a conventional
2min CO-rebreathing procedure (oCOR+20min).
2.4 Established carbon monoxide rebreathing
method
tHb-masswasdeterminedusing theoptimizedCO-rebreathing (oCOR)
method as described andmodified by Schmidt andPrommer (Prommer
& Schmidt, 2007; Schmidt & Prommer, 2005). Briefly, a bolus of
99.97% CO (0.8–1.0 ml CO/kg body mass, depending on the training
status) was administered to subjects and rebreathed along with
3 litres of 100% O2 for 2 min. Three arterialized capillary blood
samples were taken from a hyperaemic earlobe (Finalgon, Sanofi-
Aventis, Frankfurt, Germany) before the rebreathing procedure, and
at minutes 6 and 8 after the rebreathing procedure, and each sample
was analysed in triplicate using an OSM3 haemoximeter (Radiometer,
Brønshøj, Denmark). End-tidal [CO] was assessed before and 2 min
after the rebreathing procedure using a portableCOdetector (Draeger
Pac7000, Lübeck, Germany). tHb-mass was assessed in duplicate (test
1 and test 2) using this method, and the mean of both tests was used
for comparisonwith the results of themodified procedures. The typical
error for tHb-mass measurements determined from these duplicate
tests was 1.0%.
2.5 Modified method
To adapt themethod so that it can be used in everyday clinical practice,
several modifications were necessary (see Figure 1). Since a patient
frequently cannot put the spirometer into their mouth by themselves,
the gas supply was replaced by a mask (Hans Rudolph, Inc., Shawnee,
KS, USA) with an access port for the CO supply. This access port is
designed in such a way that the manually administered CO from a
syringe passes the mask via a small tube directly into the back of
the mouth and thus into the test person’s inhalation path. In contrast
to the established method, in which rebreathing occurs in a closed
system, this modification presents an open system in which ambient
air is inhaled via a three-way valve. The inhaled and expired air passes
a volume flow sensor (breath-by-breath registration, Metalyzer 3B,
Cortex Biophysics GmbH, Leipzig, Germany) and subsequently a small
mixing chamber, which is equipped with a CO sensor (Draeger Pak
7000, Liebefeld, Switzerland), and is finally collected in a Douglas bag
(Cranlea Human Performance Ltd, Birmingham, UK).
After connecting and accustoming the subject to the equipment for
at least 10 min in the sitting position, the subject exhaled normally,
and the three-way valve was turned. Subsequently, the subject deeply
inhaled, and CO was administered by the investigator via the access
port into the subject’s inhalation path. The subject held their breath
for 15 s (test 3, Procnew15s) or 30 s (test 4, Procnew30s) and breathed
normally thereafter for the following 20min into the Douglas bag.
Until the fifth minute after starting the test, the CO concentration
and the volume of the exhaled air weremonitored at 30 s intervals and
thereafter at 1 min intervals until disconnecting the subject from the
equipment after 20 min. In the same way as in test 1 and test 2, three
capillary blood samples were taken before the test, one sample each
was collected after 1 and 2 min, and then further samples were taken
every 2min until min 20.
2.6 tHb-mass calculation
For the establishedmethod (tests 1 and 2), tHb-mass was calculated as
described previously (Schmidt & Prommer, 2005):
tHb −mass (g) = K ×MCO × 100∕ (ΔCOHb% × 1.39) (1)
where K= (current barometric pressure/760) × [1+ (0.003661 ×
current temperature)],
MCO=COadm − (COsystem+lung(AfterDisconnection) +
COexhaled(AfterDisconnection) −MHb COadm
=CO volume administered into the system
COsystem+lung(AfterDisconnection)
= CO concentration in the spirometer × (spirometer volume +
lung residual volume)
MHb =COdiffusing tomyoglobin COexhaled(AfterDisconnection)
=Δ end-tidal CO concentration× alveolar ventilation× time
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F IGURE 1 Experimental set-up and equipment for the single-breathmethod. 1: breathingmask; 2: tube inserted into the subject’s inhalation
path; 3: syringe for CO administration; 4: flowmeter; 5: 3-way valve; 6: mixing chamber; 7: CO sensor; 8: Douglas bag
ΔCOHb% is the difference between basal COHb% and COHb% in
the blood samples after COadministration. 1.39=Hüfners number (ml
CO× g Hb–1) (e.g. Gorelov, 2004).
For tests 3 and 4 (Procnew15s and Procnew30s), tHb-mass was
calculated using formula (1) in two modified ways: (i) for each time
point of taking blood after CO inhalation using the corresponding
COHb concentrations and accumulated values for CO exhalation
(MCO = COadm − COexhaled − MHb), and (ii) using the COHb
concentration atmin 20 and the totally exhaledCOvolume collected in
theDouglas bag. To compare the results of the newmethodswith those
of oCOR, tHb-mass was calculated for min 7 (tHb-massmin7) as well
as using data from the whole test, that is, the mean from the plateau
between min 6 and 20 (tHb-massplateau) and for min 20 using the data
from the air collected in the Douglas bag (tHb-massDouglasBag).
2.7 Statistical analysis
Statistical analysis was performed using IBM SPSS Statistics (version
25 for Windows, IBM Corp., Armonk, NY, USA). Values are pre-
sented as themean± standard deviation (SD), unless otherwise stated.
Categorical variables are presented as frequencies (%).
This was a feasibility study, and a formal power calculation was
therefore not required. Test–retest data (repeated measures from the
same patient with different analytical methods) are presented using
Bland–Altman plots with limits of agreement (Bland & Altman, 1986).
Additionally, a specific approach to compute reliability statistics to
compare test–retest performance expressed as the typical error of
measurement (TE) was used (see Hopkins, 2000).
Student’s paired t-test was used to compare mean values from
both tests at identical time points, and a paired t-test was also used
to compare the mean values at different time points of the identical
test. All tests were two-sided, and statistical significance was set at
P < 0.05. To minimize the risk for type I errors, a correction for
multiple measurements according to Benjamini & Hochberg (1995)
was performed.
3 RESULTS
All of the tests were conducted without complications or adverse
events. All participants inhaled the identical CO volume during the
four tests (63.3± 23.1ml; males 82.1± 16.8ml, females 44.5± 6.3ml).
The exhaled CO volume was highest in the first minute of Procnew15s
(6.3 ± 3.5 ml; Procnew30s 2.9 ± 1.6 ml). This initial phase was followed
by an almost linear and parallel increase in both new procedures,
showing an accumulation of 8.7 ± 3.6 and 5.1 ± 2.0 ml in min 7
and 12.0 ± 4.4 and 8.4 ± 2.6 ml in min 20, respectively. When the
expired air was collected after oCOR+20min, the values (3.1 ± 0.3 and
5.9 ± 1.1 ml) were clearly below those of Procnew15s and Procnew30s
(Figure 2) and not different from the volume exhaled 7 min after
oCOR.
[COHb] exhibited well-known time-dependent changes, with a fast
increase in the first minute followed by a rapid and then decelerating
decrease during the rest of the observation period (Figure 3). The
values of the newprocedureswere clearly below those of oCOR+20min.
In min 7, the CO volume ligated to Hb was 59.5 ± 22.5 ml (oCOR),
57.2 ± 21.5 ml (Procnew30s) and 53.9 ± 21.6 ml (Procnew15s),
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F IGURE 2 Cumulative CO volume exhaled after the three
different methods of CO application. n= 6; Procnew15s: single CO
bolus inhalation with 15 s breath holding; Procnew30s: single CO bolus
inhalation with 30 s breath holding; oCOR+20min: 2 min CO
rebreathing followed by an 18min analysis of exhaled air
F IGURE 3 Changes in carboxy-haemoglobin ([COHb])
concentration after the inhalation of CO by three different application
methods. n= 6; Procnew15s: single CO bolus inhalation with 15 s
breath holding; Procnew30s: single CO bolus inhalation with 30 s
breath holding; oCOR+20min: 2 min CO rebreathing followed by an
18min analysis of exhaled air
corresponding to 94.0 ± 2.1%, 90.4 ± 4.7% and 85.2 ± 6.0% of the
inhaled CO volume, respectively.
tHb-masswas calculated formin 1 and 2 and then furthermeasured
in 2 min steps until min 20. We found increasing tHb-mass values
for Procnew15s until min 6 (Figure 4a) and for Procnew30s until min
8 (Figure 4b) followed by a plateau after both procedures until min
20. Comparing the tHb-mass determined at min 7 yielded similar
results for the three methods (Table 2). When tHb-mass from oCOR
was compared with tHb-massplateau and tHb-massDouglasBag, we found
slightly lower values for Procnew15s and very similar values for
Procnew30s (Table 2). Comparison of tHb-mass values obtained with
the established method (oCOR) and with oCOR+20min, that is, with
collection of the expired air as in Procnews, yielded almost identical
results (Table 2).
Bland–Altman plots comparing oCOR and the new procedures
demonstrate slightly lower tHb-mass values for Procnew15s (tHb-
massplateau: −21.8 ± 15.3 g; tHb-massDouglasBag: −12.2 ± 24.2 g) and
very similar values for Procnew30s over a large range of tHb-mass
values between 450 and 1300 g (Figure 5).
4 DISCUSSION
We wished to identify a way to measure tHb-mass in mechanically
ventilated patients. We thus explored whether it is possible to reliably
measure tHb-mass using a single-breath inhalation (with a 15 or 30 s
breath hold) of CO gas and showed for the first time that it is feasible
(Procnew). Exhaled gas was collected and measured for the duration
of the testing period (20 min). Our data suggest that Procnew with
15 and 30 s breath holds was closely related to the established CO-
rebreathingmethod.
The principle of the CO-rebreathing method is to administer a
defined amount of CO by breathing to determine the resulting COHb
concentration in the completely mixed blood and to take into account
the CO not bound to the Hb, that is CO exhaled and CO diffused to
myoglobin.When these conditions are fulfilled, different procedures of
the COmethod can be applied.
Modifications to the CO rebreathing technique for the
measurement of tHb-mass have therefore been made many times
since the technique was revived by Fogh-Andersen et al. (1990),
notably in 1995 when Burge and Skinner achieved improved precision
of the measurement (Burge & Skinner, 1995). The current technique
described by Schmidt and Prommer reduced the rebreathing period
to only 2 min to improve convenience for participants (Otto et al.,
2017a,b; Plumb et al., 2020; Schmidt & Prommer, 2005). The finding
that a bolus of CO gas inhaledwith a single breath and only rebreathed
for 2 min led to valid and reliable results characterized by a typical
error between 1% and 2% allowed the method to be used in a variety
of different settings. Initially, these were primarily focused on elite
sports physiology and performance, but more recently, oCOR has also
been used to answer clinical questions (Otto et al., 2017a,b). The high
reliability is confirmed in this study with a TE of 1.0% for the standard
oCORmethod.
When CO is administered for tHb-mass determination in an open
spirometry system as we did in this study for the first time, an exact
determination of the exhaled CO is mandatory. We determined the
exhaled CO volume twice, that is, first by continuously monitoring
the volume and CO concentration of the exhaled air, and second
by collecting the whole amount of expired air in a Douglas bag and
measuring the exhaled CO volume after the test.
To check whether the breathing procedure after the test exerts
any unexpected influence on CO exhalation, we compared a 2-
min inhalation period with subsequent collection of exhaled air
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F IGURE 4 Time course of the calculated tHb-mass after CO breathing and subsequent breath holding for 15 s (a; Procnew15s) and for 30 s (b;
Procnew30s). Presented aremean values and individual data of the tHb-mass calculated for different time points of blood sampling. Significant
differences from previous values: *P≤ 0.05, **P≤ 0.01, ***P≤ 0.001
TABLE 2 tHb-mass calculated from the three CO applicationmethods
oCOR(n= 11) Procnew15s(n= 11) Procnew30s(n= 11) oCOR(n= 6) oCOR+20min(n= 6)
tHb-massmin7 (g) 843± 293 819± 285 838± 301 705± 209 665± 194
tHb-massplateau (g) 821± 288* 849± 311 686± 200
tHb-massDouglasBag (g) 830± 276 846± 309 711± 196
oCOR: establishedCO-rebreathingmethod; Procnew15s: singleCObolus inhalationwith 15 s breath holding; Procnew30s: singleCObolus inhalationwith 30 s
breath holding; oCOR+20min: 2minCO rebreathing followed by an 18min analysis of exhaled air; tHb-massmin7: tHb-mass calculatedwith [COHb] determined
7min after inhalation, tHb-massplateau: Hb-mass calculatedwith [COHb] determined betweenmin 6 andmin 20, tHb-massDouglasBag: tHb-mass calculatedwith
[COHb] determined at min 20 and using the CO volume exhaled into the Douglas bag. Significant difference from oCOR: *P< 0.05.
(oCOR+20min) with the established method (oCOR). As we did not
find any difference in the resulting tHb-mass, we conclude that
the exhalation protocol does not affect the precision of the new
procedures.
When breath was held for 15 s, the initial CO exhalation after
1 min was twice as high as that in Procnew30s, indicating that ∼10%
(Procnew30s ∼4%) of the inhaled CO did not diffuse into the blood.
After 7 min, that is, when the CO mixing in the blood was completed
and therefore used in the established oCOR for blood sampling after
the test, the loss of CO was ∼13% in Procnew15s and only ∼8% in
Procnew30s. Although this loss in CO clearly exceeded the CO volume
exhaled after oCOR (∼4%), these data demonstrate the rapid diffusion
of CO from the lungs into the blood, which is also a precondition for
the determination of the lung diffusion capacity by means of a deep
inhalation of a 0.3% CO-containing gas followed by a 10-s breath hold
(Modi & Cascella, 2020). We therefore suggest that tHb-mass might
be easily and exactly calculated after a single breath when considering
sufficient mixing time of the inhaled CO bolus.
These considerations are supported by the calculated tHb-mass
over time. In the new procedures, tHb-mass reached a plateau in min
6 or in min 8 indicating complete mixing (Bruce & Bruce, 2003), that
is, that any time point beyond can be used for tHb-mass and blood
volume determination (Wachsmuth et al., 2019). In this study, we used
the plateau value between min 6 and 20 and compared its mean with
the time point usually used in the oCOR (min 7) and with the results
obtained in min 20 from the exhaled air collected in the Douglas bag.
As shown in Table 2, there is no obvious difference between tHb-mass
obtained from theoCORand that obtained from thenewprocedures at
the time pointsmentioned above. In the Bland–Altman plot, a small but
systematic underestimation by approximately 25 g compared with the
referencemethod becomes obvious in Procnew15s. As such a deviation
does not occur between Procnew30s and oCOR, we suggest that the
smaller CO volume taken up from the blood during Procnew15s may
be the cause. Additionally, the very low limits of agreement in the
comparison of both newmethods with oCOR indicate that Procnew15s
already presents a promising tool for tHb-mass and blood volume
determination, and Procnew30s seems to be as exact as the established
oCOR.
In future studies, the administration of higher CO volumes
than those used for the oCOR may be taken into consideration
to compensate for the lower CO uptake during the single-breath
application. On the one hand, this procedure increases the [COHb],
reducing the measurement error of the CO oximeter (Alexander et al.,
2011) but also increases the volume of exhaled CO and thereby
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F IGURE 5 Bland–Altman plots for the comparison of tHb-mass values achieved from the new procedures (a, Procnew15s; b, Procnew30s) with
the established CO-rebreathingmethod (cCOR). Long dashed lines represent themean and SD of tHb-massplateau (Hb-mass calculated with
[COHb] 6–20min after inhalation); short dashed lines represent themean and SD of tHb-massDouglasBag (tHb-mass calculated with [COHb] 20min
after inhalation and the CO volume collected in the Douglas bag)
introduces another source of inaccuracy. In the literature, there has
also been extensive debate about the merits of having a higher
[ΔCOHb%] versus the increased toxicity risk (Alexander et al., 2011;
Garvican et al., 2010; Turner et al., 2014). [COHb] of up to 10% has
been described without remarkable side effects in healthy subjects
(Schmidt et al., 2020), but to our knowledge, it has never been studied
in seriously ill patients. Because CO is endogenously produced and is
actually considered for the treatment of various diseases (Motterlini
& Otterbein, 2010), we are convinced that the increase in COHb by
4–5%, as achieved in our study, represents a reliable compromise
balancing sources of error withminimal patient risk.
4.1 Practical application
We hypothesize that this method might be used to diagnose and
provide more information on the origin of anaemia in intensive care
(Magee & Zbrozek, 2013) and the amount of blood loss during
surgery (Shoemaker et al., 1996), as well as for distinguishing between
dilutional anaemia and genuine anaemia in patients with heart failure
(Miller & Mullan, 2015) and liver failure (Plumb et al., 2020). Here,
it is of critical importance that the modified method has sufficient
accuracy to reveal clinically relevant changes in tHb-mass and their
contribution to changes in [Hb]. Although the reliability of themodified
method was not explicitly determined in this feasibility study, the
methodological error (typical error, TE; Hopkins, 2000) compared to
the established method is 3.2% (Procnew30s) or 3.5% (Procnew15s).
This is higher than the TE of the established CO rebreathing methods
(TE 2.2%) but close to the TE of the gold standardmethods using radio-
active markers (51Cr, 2.8%; Gore et al., 2005). Since even mild real
anaemic states ([Hb] 11.2 g/dl) are associated with a reduction of at
least ∼15% tHb-mass (Wachsmuth et al, 2015), the accuracy of the
method should be sufficient to distinguish anaemia due to reduced
tHb-mass from that due to dilution. This contention is supported by
Otto et al. (2017a) who describe two patients with liver disease who
had identical tHb-mass (9.2 g/kg body mass), but with a normal [Hb]
(16.1 g/dl) in one and dilutional anaemia ([Hb] 10.7 g/dl) in the other.
They also describe two cases of heart failure in which the presence of
a severe reduction in tHb-mass (5.2 g/kg) was reflected in a low [Hb] in
one (6.9 g/dl), butmasked by a contractedPV in another ([Hb] 10.7 g/dl)
(Allsop et al., 1998; Otto et al. (2017a). In addition to the frequently
occurring dilution anaemia, decompensated heart failure can also
be associated with proportional increases in both tHb-mass and PV
(Miller, 2016). In all these cases, the determination of the tHb-mass,
also when using the modified method, enables a much more precise
diagnosis.
The modification described here may permit the CO method to be
used in ventilated patients. CO is applied to the inhalation path, and
breathing is interrupted in the inhalation position for 15 or 30 s. The
CO volume not absorbed by the patient can be determined either
by collecting the entire expiratory air for a period of approximately
20 min or by continuous monitoring of the volume of the expired air
and its CO concentration. These measurements are carried out until
the CO is completely mixed in the blood and a blood sample for the
determination of COHb is drawn.
The application of our approach to ventilated patients would
offer possible clinical advantages. In most patients treated in an
intensive care unit, the [Hb] drops significantly within a few days and
transfusions are recommended when [Hb] reaches a threshold of
70 g/l (Watson & Kendrick, 2014) without excluding dilution. Indeed,
there is no routine way in which to assess intravascular volume,
with central venous pressure being a very poor guide indeed (De
Backer & Vincent, 2018). In addition, blood and fluid loss during
surgery are imprecisely measured and this, together with altered
cardiovascular tone, and the variable administration of packed red
blood cells and crystalloid/colloid solutions, makes determination of
574 KREHL ET AL.
intravascular volume (and of true Hb deficit) difficult. Ourmethodmay
find application in all such situations.Nonetheless, the applicability and
validity of this ‘single breathmethod’ remains to be validated in clinical
circumstances.
In such clinical studies CO mixing time must be considered. It is
prolonged inpatientswithpolycythaemia (Wachsmuthet al., 2019) and
heart failure (Ahlgrim et al., 2018), and perhaps also in other patient
groups. This should, however, not be a major problem as the exhaled
CO is collected for 20 min and a significant increase in mixing time
can be tolerated if the individual COHb plateau is determined for
each patient after inhalation of the CO. The use of the new method in
patientswithpulmonarydiffusiondisorders couldbemoreproblematic
if sufficient CO cannot diffuse from the alveoli into the blood within
30 s. Higher CO doses may have to be used in such circumstances, but
this can have an adverse effect on the accuracy of the test.
In healthy subjects, there is no risk of interrupting breathing for 30 s,
and the risk can be classified as very low also in ventilated patients.
Since the oxygen consumption during the 30-s breath interruption is
only approximately 150 ml, the arterial O2 saturation does not change
during this period (Parkes et al., 2016); but in any case, it must be
checkedduring and after the test. In severely anaemic patients, the test
might be usedwith great caution after extensive validation.
5 CONCLUSION
Using the single-breath method, tHb-mass and blood volume can
be determined with approximately the same accuracy as that with
established CO-rebreathing methods. We recommend that this
method be developed further for use in ventilated patients, that is,
patients in intensive care, patients undergoing major surgery, and
patients with heart and liver failure.
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